Related content

Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

By Takeuchi Tsutomu  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 226-235

Springer Publishing Company

Access to resources Recommend Favorite

Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients

By Kameda Hideto   Amano Koichi   Sekiguchi Naoya   Takei Hirofumi   Ogawa Hiroe   Nagasawa Hayato   Takeuchi Tsutomu  

Modern Rheumatology, Vol. 14, Iss. 6, 2004-12 ,pp. : 442-446

Springer Publishing Company

Access to resources Recommend Favorite

Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents

By Miwa Yusuke   Hosaka Michio   Ohtsuka Kumiko   Sato Michihito   Takahashi Ryo   Wakabayashi Kuninobu   Odai Tsuyoshi   Yajima Nobuyuki   Kasama Tsuyoshi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 920-924

Springer Publishing Company

Access to resources Recommend Favorite

Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients

By Takahashi Nobunori   Kojima Toshihisa   Terabe Kenya   Kaneko Atsushi   Kida Daihei   Hirano Yuji   Fujibayashi Takayoshi   Yabe Yuichiro   Takagi Hideki   Oguchi Takeshi   Miyake Hiroyuki   Kato Takefumi   Fukaya Naoki   Ishikawa Hisato   Hayashi Masatoshi   Tsuboi Seiji   Kato Daizo   Funahashi Koji   Matsubara Hiroyuki   Hattori Yosuke   Hanabayashi Masahiro   Hirabara Shinya   Yoshioka Yutaka   Ishiguro Naoki  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 904-912

Springer Publishing Company

Access to resources Recommend Favorite

Durability of therapeutic response in rheumatoid arthritis: clinical trial experience with abatacept

By Shergy William  

Future Rheumatology, Vol. 3, Iss. 6, 2008-12 ,pp. : 507-516

Future Medicine

Access to resources Recommend Favorite